Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis

NCT05647096 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
73
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Santersus AG

Collaborators